• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      CRISPR Combined with Glowing Proteins for Viral Detection

      CRISPR Combined with Glowing Proteins for Viral Detection

      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

    • Radiology
      Imaging Technique Reveals Contraction Patterns During Labor

      Imaging Technique Reveals Contraction Patterns During Labor

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

      Antibacterial Smart Sutures Visible in CT Scans

      Antibacterial Smart Sutures Visible in CT Scans

    • Cardiology
      Scientists Grow Electrodes Inside The Body

      Scientists Grow Electrodes Inside The Body

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

    • Surgery
      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Self-Assembling Peptides as a Bioink

      Self-Assembling Peptides as a Bioink

    • Nanomedicine
      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Anticoagulant Market estimate to reach US$ 57,337.5 Mn by 2028 with CAGR of 9.4% | Pfizer Inc., Sanofi SA, Dr. Reddy’s Laboratories, Aspen Holdings

February 6th, 2023 Coherent Market Insights Releases

Anticoagulant Market

Globally, the market for anticoagulant was priced at US$ 30,773.2 million in the year 2021 and is estimated to the extent of US$ 57,337.5 million by the end of the year 2028 at a CAGR of 9.4% from 2022 to 2028. The market of anticoagulant is witnessing robust development owing to the developing incidence of prolonged disease in need for anticoagulants worldwide. Furthermore, increase in emphasis on the growth of new anticoagulants and increasing elderly (geriatric) population worldwide is anticipated to fuel the market growth. Though, factors like aide effects related with anticoagulants and strict government rules are anticipated to hinder the market growth of anticoagulants across the world.

Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/5486

Global Anticoagulant Market: Regional Insights

On the basis of geography, the market of anticoagulant worldwide is divided into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa.

Amongst region, North America is anticipated to have the major market share in the predicted period owing to the rise in prevalence of prolonged diseases, mainly cardiovascular diseases (CVD’s) and increase in use of new oral anticoagulants (NOACs)  in the region. For example, as per AHA (American Heart Association) report of October 2021, more than 2,300 people in U.S die owing to CVDs every day, which is 1 death in 38 seconds on an average. Therefore, with the rise in incidence of CVDs, need for coagulants are also rising, thus pushing the market growth.

Asia Pacific is also anticipated to experience substantial growth of anticoagulant’s market worldwide owing to the rise in incidence of CVD’s and rise in need for anticoagulants in this region. For example, anticoagulants plays vital role in treating CVDs.  India’s problem of cardiovascular disease is highest across the world. As per National Center for Biotechnology Information, the number of deaths in a year from cardiovascular disease in India is anticipated to rise from 2.26 Mn in the year 1990 to 4.77 Mn in the year 2020. This has raised the need for anticoagulants in the region.

Global Anticoagulant Market Drivers

Increasing incidence of prolonged diseases worldwide is anticipated to fuel the market growth of the anticoagulant across the world in the predicted period. For example, DOACs (Direct oral anticoagulants) are needed in preventing and treating CVDs. Direct oral anticoagulants are anticoagulation pharmacotherapy needed for preventing thrombosis in many cardiovascular reference. As per WHO (World Health Organization), CVDs are the main root of death worldwide, taking a projected 17.9 Mn lives every year. This is anticipated to raise the need for anticoagulants worldwide.

Rise in need for anticoagulants worldwide is anticipated to fuel the market growth of the anti-coagulant worldwide in the predicted period. For example, Natco Pharma in December 2020 announced the introduction of an antiblood clot tablet known as Rivaroxaban, which is used in treating and preventing clotting of blood. The tablet is at present sold by Bayer with the brand name of Xarelto in the msrket of India. Natco has introduced RPIGAT in strengths of four, 20 mg, 15 mg, 10 mg, and 2.5 mg. The new oral anti-coagulant, Rivaroxaban is following the Natco’s mission of making medicines affordable that can be easily accessed by everyone, as released from a Natco Pharma.

Global Anticoagulant Market Opportunities

Increasing in emphasis on the growth of new anticoagulants is anticipated to offer substantial opportunities of growth for the companies in the market of anticoagulant across the world. For example, with the increase in the problem of prolonged diseases across the world, the need for safe and real anticoagulants is also rising with increased pace. The United States National Institutes of Health (NIH) in March 2020, started the remaining last three Phase III medical trials of blood thinners (anticoagulant) in preventing life-threatening clotting of blood in adults with the coronavirus disease (COVID-19)

Increasing elderly population worldwide is anticipated to provide profitable opportunities of growth for the companies in the market of anticoagulant across the globe. For example, the need for unplanned and non-invasive treatments is increasing among the elderly population which has augmented the need for coagulants across the world. AS per WHO, by the end of the year 2030, 1 in every 6 people in the globe will age 60 years and more and by the end of the year 2050, the population of the world of people aging 60 years and more will get double which is 2.1 Bn.

Buy This Premium Report with Amazing Offer (Up to 25% Off) @ https://www.coherentmarketinsights.com/insight/buy-now/5486

Global Anticoagulant Market Trends

There is a rise in need for DOACs (direct oral anticoagulants) worldwide. The expansion and the introduction of DOACs (direct oral anticoagulants) signify a vast development in the anticoagulation field. Furthermore, the use of NOACs (new oral anticoagulant) is rising or has been raised in the emerging countries and is expected to exhibit same fashion in the predicted period due to the high liking of new oral anticoagulants over the warfarin.

Furthermore, the application of anticoagulants is rising, due to the rising application of plasma in the pharmaceutical industry. Without this, in clinical usages also, anticoagulants are needed. These extensive usages from anti-tumor and anti-inflammatory in order to prevent the infectious disease and the application of nano-carriers for delivery of drug. This fashion is anticipated to last in the predicted period, pushing the growth of the market.

Global Anticoagulant Market Restraints

The after effects related with some anticoagulant are anticipated to hinder the market growth of the anticoagulant worldwide. For example, medicines of anticoagulant can result in after effects which may cause serious complications. Common after effects in relation to anticoagulants is bleeding. On the basis of medicine used, other possible risks also occur. They cause upset stomach, nausea, diarrhea and others.

Strict regulations of the government are anticipated to hamper market growth of the anticoagulant. The application of oral anticoagulants is being observed for negative drug activities. For example, US FDA (United States Food and Drug Administration) uses normal surveillance meanings in relation to anticoagulant bleeding trials in post marketing and analysis by epidemiology, to avail the exactness of diagnostic and coding by procedure to arrest anticoagulant-associated bleeding activities.

Global Anticoagulant Market Segmentation

Globally, the market report of anticoagulant is divided into drug class, geography and application.

On the basis of drug class, the market is classified into Heparin, Low-molecular- weight Heparin (LMWH), Novel Oral Anticoagulants (NOACs), and Vitamin K Antagonist. Amongst which, the market of Novel Oral Anticoagulants (NOACs) Segment is anticipated to control the market of anticoagulant in the predicted period and this is credited to the rise in use of NOACs which helps in preventing clot formation and protecting a person from many types of strokes.

The segment of Heparin and Low-Molecular-Weight Heparin (LMWH) Segment is also anticipated to experience substantial growth in the coming future and this due to the rise in problem of prolonged diseases. LMWH aids in treating cancer-associated clot of blood, since it is more in effect than warfarin.

On the basis of application, the market is classified into Pulmonary Embolism,  Deep Vein Thrombosis (DVT), Atrial Fibrillation/Myocardial Infarction (Heart Attack), and Other Applications. Amongst which, the segment of Atrial Fibrillation/Myocardial Infarction (Heart Attack) Segment is anticipated to control the market in the predicted period and this is credited to the rise in prevalence of CVDs worldwide.

The segment of Deep Vein Thrombosis (DVT) Segment is anticipated to experience substantial growth in the coming future and this is due to the rise in application of anticoagulants. Anticoagulant therapy rests the backbone of clinical therapy for DVT (deep venous thrombosis)

Global Anticoagulant Market: Key Developments

Janssen Pharmaceuticals Companies of Johnson & Johnson announced in October 2019 that the US FDA permitted Xarelto (Rivaroxaban) in preventing venous thromboembolism (VTE).

Bristol-Myers Squibb-Pfizer Alliance declared in March 2019 results of Phase 4 AUGUSTUS trial assessing Eliquis (apixaban) versus vitamin K antagonists (VKAs) in person with non-valvular atrial fibrillation (NVAF) and the new ACS (acute coronary syndrome) or undergoing PCI (percutaneous coronary intervention)

Global Anticoagulant Market: Key Companies Insights

Globally, the market of anticoagulant is very much competitive in type. This is accredited to the increase in need or rise in use of anticoagulants worldwide, consequently, companies are emphasizing on introducing new products in the market.

The main companies in the market of anticoagulants worldwide includes Pfizer Inc., Sanofi SA, Dr. Reddy’s Laboratories, Aspen Holdings, Abbott Laboratories, Leo Pharma AS, Alexion Pharmaceuticals Inc., Bayer AG, Johnson & Johnson, Bristol-Myers Squibb Company, Daiichi Sankyo Company, and Boehringer Ingelheim Pharmaceuticals Inc., among others.

Get your Customized Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/5486

Table of Contents:

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug Class
      • Market Snapshot, By Application
      • Market Snapshot, By Geography
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Growing prevalence of chronic diseases across the globe
      • Stringent government regulations
      • Rise in focus on the development of novel anticoagulants
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product launch/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario

Check Out More Related Reports:

Lyophilized product market

Acute ischemic stroke therapeutics market

Anticoagulant reversal drugs market

Lyophilized drugs market 

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Mr. Shah

Coherent Market Insights Pvt Ltd,

533 Airport Boulevard, Suite 400, Burlingame

CA 94010, United States

Email: sales@coherentmarketinsights.com

Phone: U.S.: +1-206-701-6702

U.K.: +44-020-8133-4027

JAPAN: +81-50-5539-1737

INDIA: +91-848-285-0837

Sign up and submit a press release

Sponsored
Venture builder BHV Partners launches Conus Airway to improve anaesthesia  and respiratory surgery

Venture builder BHV Partners launches Conus Airway to improve anaesthesia and respiratory surgery

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

interviews & reviews
Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email